Bowleven (BLVN.GB) Share Price

The NUMBER ONE thing everyone on this board wants to know is how much is Elite's ART technology worth just based on potential, without us ever bringing an ART product to market.

Nasrat: "Our patents and know-how have a lot of value, and they add to the company's valuation, okay? An

Lets be honest here. While those financials are for previous periods and there are still more that need to be submitted, they are new and not re-filed as you claim (I'm not sure if you are mistaken, lying, or stupid). What kind of person claims as fact to know what someone else is thinking or their

Please, feel free to discuss in detail here:

https://investorshub.advfn.com/boards/profileb.aspx?user=8777

Brave or just late to the game? Those who were paying attention could have bought all they wanted in the trips if they were paying attention. There are many more like him that are making their decision for an entry point who don't realize that there are even more people waiting to buy more when the

Iclight, again you are pretending to be smarter than the 73 CoAuthors of the Journal Article. Fortunately, we all know this is far from the truth even though we don’t know your name or level of education.

$VXIT--the updates just keep coming.
building a real company . noones selling as they know its going to copper-silver!
https://web.facebook.com/watch/?mibextid=xCPwDs&v=455915450490264&rdid=tEkXcftwHZ75VZqR

Not yet Truth. But I’m betting that will change once the merger is done

LWLG's TOP Competition is TFLN which is LAUGHABLE!!!

TFLN? here worth another LQQk,

TFLN isn’t ready. Unless HyperLight drastically expanded their production line and figured out their stability issues, they aren’t able to supply the market.

Liobate. No.

$VXIT--the updates just keep coming.
building a real company
https://web.facebook.com/watch/?mibextid=xCPwDs&v=455915450490264&rdid=tEkXcftwHZ75VZqR

America will be great again when the convicted felon/rapist strokes out. The entire world will celebrate!

$VXIT--the updates just keep coming.
building a real company
https://web.facebook.com/watch/?mibextid=xCPwDs&v=455915450490264&rdid=tEkXcftwHZ75VZqR

Great......now the brainwashed parrot is using "more cowbell please" on every ticker's message board. Poor wittle Jimmy. So sad......

https://web.facebook.com/watch/?mibextid=xCPwDs&v=455915450490264&rdid=tEkXcftwHZ75VZqR

Trump has been backed by the wrong people if you think he alone can save america

https://x.com/Angry_Staffer/status/1808602985934602483

Smelling whales here again. We shall see tomorrow.


Pessimistic bitches just be quiet here as you always seem to put a stinky foot in your mouth.

https://www.linkedin.com/feed/update/urn:li:activity:7213771605687046144/?origin=NETWORK_CONVERSATIONS&midToken=AQGbTTnYdLi7LQ&midSig=3sOV-q6Hswtbk1&trk=eml-email_network_conversatio

It was better not getting this tweet for him on a July 4th holiday.
This will probably make the share price go further south.
I am just saddened by his fluff statements lately!!!
I really hope he is NOT one of those typical scumbag OTC CEOs that only cares about their own pock

https://x.com/Angry_Staffer/status/1808602985934602483

100% per cent correct

Ray Charles Performs 'America the Beautiful' at Game 2 of the 2001 World Series, October of '01
https://www.youtube.com/watch?v=1OTRRzSuWro

Sumcoin Index ?? [SUM]
@SumcoinIndex
“#Sumcoin is no longer a part of our business model.” By stating this publicly, they have effectively opted out of any future claims or participation in Sumcoin, including any transitions involving Slice Wallet to Sumcoin Wallet migration, which jus

As the summer of 2021 enters its final months, investors in the U.S. over-the-counter market and OTC issuers themselves await the rollout of the amended Securities and Exchange Commission (“SEC”) Rule 15c2-11 on September 28. The rule is vital to the penny stock market: no OTC security can begin tra

Roche reported today that its Phase 2-3 Skyscraper-06 trial of Tiragolumab + Tecentriq + chemotherapy failed to meet the primary endpoints, OS and PFS, in NSCLC.

Further, the Tecentriq arm actually reduced OS and PFS when assessed against the comparator arm of pembrolizumab + chemoth